19 June 2013
Keywords: speedel, starts, ph, spp1148, testing, switzerland, initiated
Article | 22 January 2007
Switzerland's Speedel has initiated a Phase I trial of SPP1148, its most-promising compound from a new series of renin inhibitors ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 January 2007
© 2013 thepharmaletter.com